AVAXIA BIOLOGICS, Inc — Form D/A
AVAXIA BIOLOGICS, Inc of LEXINGTON, MA, a company, filed a Form D amendment with the SEC on 2012-01-06. The offering totals $4.5M, of which $3.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2012-01-06
- Form: D/A
- Accession: 0001534899-12-000001
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $4.5M
- Amount sold: $3.4M
- Remaining: $1.0M
- Investors: 94
- Date of first sale: 2011-11-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-168953
Issuer
- Name: AVAXIA BIOLOGICS, Inc
- CIK: 0001534899
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 128 SPRING ST., STE 620, LEXINGTON, MA, 02421
- Phone: 781-861-0062
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Jonathan S Fleming | Director | Lexington, MA |
| John S Edwards | Director | Lexington, MA |
| Christopher S Kiritsy | Director | Lexington, MA |
| Henry S Kay | Director | Lexington, MA |
| David S Poorvin | Director | Lexington, MA |
| David S Poorvin | Executive Officer | Lexington, MA |
| Nada S Jain | Director | Lexington, MA |
| David S Donabedian | Director | Lexington, MA |
| Robert S Manning | Director | Lexington, MA |
| Barbara S Fox | Director | Lexington, MA |
| Barbara S Fox | Executive Officer | Lexington, MA |
| David H Donabedian | Director | Lexington, MA |
| David C Dlesk | Executive Officer | Lexington, MA |
| Christopher F Kiritsy | Director | Lexington, MA |
| Eileen F Bostwick | Executive Officer | Lexington, MA |
Other filings by this issuer (6)
More